FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Franco Leoni

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Alessandro Pulsoni; Simona Iacobelli; Massimo Bernardi; Marco Borgia; Andrea Camera; Nicola Cantore; Francesco Di Raimondo; Paola Fazi; Felicetto Ferrara; Franco Leoni; Vincenzo Liso; Marco Mancini; Filippo Marmont; Angela Matturro; Luca Maurillo; Lorella Melillo; Giovanna Meloni; Salvo Mirto; Giorgina Specchia; Caterina Giovanna Valentini; Adriano Venditti; Giuseppe Leone; Robin Foà; Franco Mandelli; Livio Pagano
M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience.
Felicetto Ferrara; Salvatore Palmieri; Franco Leoni
Clinically useful prognostic factors in acute myeloid leukemia.
Rainer Glauben; Arvind Batra; Thomas Stroh; Ulrike Erben; Inka Fedke; Hans-Anton Lehr; Franco Leoni; Paolo Mascagni; Charles A Dinarello; Martin Zeitz; Britta Siegmund
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Franco Leoni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Alessandro Pulsoni; Simona Iacobelli; Massimo Bernardi; Marco Borgia; Andrea Camera; Nicola Cantore; Francesco Di Raimondo; Paola Fazi; Felicetto Ferrara; Franco Leoni; Vincenzo Liso; Marco Mancini; Filippo Marmont; Angela Matturro; Luca Maurillo; Lorella Melillo; Giovanna Meloni; Salvo Mirto; Giorgina Specchia; Caterina Giovanna Valentini; Adriano Venditti; Giuseppe Leone; Robin Foà; Franco Mandelli; Livio Pagano
M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience.
Haematologica 2008;93(7):1025-32.
2008: Felicetto Ferrara; Salvatore Palmieri; Franco Leoni
Clinically useful prognostic factors in acute myeloid leukemia.
Critical reviews in oncology/hematology 2008;66(3):181-93.
2008: Rainer Glauben; Arvind Batra; Thomas Stroh; Ulrike Erben; Inka Fedke; Hans-Anton Lehr; Franco Leoni; Paolo Mascagni; Charles A Dinarello; Martin Zeitz; Britta Siegmund
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice.
Gut 2008;57(5):613-22.
2008: Giacomo Gianfaldoni; Francesco Mannelli; Sara Bencini; Franco Leoni; Simone Baldini; Alberto Bosi
Peripheral blood blast clearance during induction therapy in acute myeloid leukemia.
Blood 2008;111(3):1746-7.
2008: Rosa Fanci; Franco Leoni; Giovanni Longo
Nosocomial infections in acute leukemia: comparison between younger and elderly patients.
The new microbiologica 2008;31(1):89-96.
2007: Silvia Bertuglia; Hideo Ichimura; Gianluca Fossati; Kaushik Parthasarathi; Franco Leoni; Daniela Modena; Piero Cremonesi; Jahar Bhattacharya; Paolo Mascagni
ITF1697, a stable Lys-Pro-containing peptide, inhibits weibel-palade body exocytosis induced by ischemia/reperfusion and pressure elevation.
Molecular medicine (Cambridge, Mass.) 2007;13(11-12):615-24.
2007: Josée Golay; L Cuppini; Franco Leoni; Caterina Micò; V Barbui; M Domenghini; L Lombardi; A Neri; Anna Maria Barbui; Anna Salvi; Pietro Pozzi; Giulia Porro; Paolo Pagani; Gianluca Fossati; Paolo Mascagni; Martino Introna; Alessandro Rambaldi
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells.
Leukemia 2007;21(9):1892-900.
2007: Salvatore Palmieri; Felicetto Ferrara; Franco Leoni; Stefania Ciolli; Filiberto Pollio; Maria Rosaria D'Amico; Maria Celentano; Assunta Viola; Laura Vicari; Barbara Izzo; Fabrizio Pane
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.
Hematological oncology 2007;25(1):1-5.
2006: Giuseppe Faraco; Tristano Pancani; Laura Formentini; Paolo Mascagni; Gianluca Fossati; Franco Leoni; Flavio Moroni; Alberto Chiarugi
Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.
Molecular pharmacology 2006;70(6):1876-84.
2006: Vanessa Ponziani; Giacomo Gianfaldoni; Francesco Mannelli; Franco Leoni; Stefania Ciolli; Paola Guglielmelli; Elisabetta Antonioli; Giovanni Longo; Alberto Bosi; Alessandro M Vannucchi
The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients.
Leukemia 2006;20(11):2074-6.
2006: Giacomo Gianfaldoni; Francesco Mannelli; Michela Baccini; Elisabetta Antonioli; Franco Leoni; Alberto Bosi
Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study.
British journal of haematology 2006;134(1):54-7.
2006: Rainer Glauben; Arvind Batra; Inka Fedke; Martin Zeitz; Hans-Anton Lehr; Franco Leoni; Paolo Mascagni; Giamila Fantuzzi; Charles A Dinarello; Britta Siegmund
Histone hyperacetylation is associated with amelioration of experimental colitis in mice.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(8):5015-22.
2006: Stefania Ciolli; Franco Leoni; F Gigli; Luigi Rigacci; Alberto Bosi
Low dose Velcade, thalidomide and dexamethasone (LD-VTD): an effective regimen for relapsed and refractory multiple myeloma patients.
Leukemia & lymphoma 2006;47(1):171-3.
2006: Carlo Nozzoli; Benedetta Bartolozzi; Stefano Guidi; A Orsi; Alessandro M Vannucchi; Franco Leoni; Alberto Bosi
Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation.
Leukemia & lymphoma 2006;47(1):167-9.
2005: Rosa Fanci; C Casini; Franco Leoni
Empiric antifungal strategies for acute leukemia patients.
Journal of chemotherapy (Florence, Italy) 2005;17(1):115-6.
2005: Franco Leoni; Gianluca Fossati; Eli C Lewis; Jae-Kwon Lee; Giulia Porro; Paolo Pagani; Daniela Modena; Maria Lusia Moras; Pietro Pozzi; Leonid L Reznikov; Britta Siegmund; Giamila Fantuzzi; Charles A Dinarello; Paolo Mascagni
The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo.
Molecular medicine (Cambridge, Mass.) 2005;11(1-12):1-15.
2004: Rosa Fanci; C Casini; Franco Leoni; Stefania Ciolli; Alberto Bosi
Incidence and management of proven and probable fungal infections in patients with acute leukemia: a single center experience.
Journal of chemotherapy (Florence, Italy) 2004;16(6):557-60.
2004: Emanuela Barletta; Giuseppe Gorini; Paolo Vineis; Lucia Miligi; Laura Davico; Gabriele Mugnai; Stefania Ciolli; Franco Leoni; Marilena Bertini; Giuseppe Matullo; Adele Seniori Costantini
Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents.
Carcinogenesis 2004;25(5):749-55.
2004: Stefania Ciolli; Alessandro M Vannucchi; Franco Leoni; Carlo Nozzoli; Giovanni Longo; A Salati; Alessandro Pancrazzi; Lucia Bianchi; F Gigli; Alberto Bosi
Internal tandem duplications of Flt3 gene (Flt3/ITD) predicts a poor post-remission outcome in adult patients with acute non-promyelocytic leukemia.
Leukemia & lymphoma 2004;45(1):73-8.
2003: Monica Biscardi; Roberto Caporale; Gabriella Pagliai; Franco Leoni; Pietro Antonio Bernabei; Valeria Santini; Stefania Ciolli; Alberto Grossi
In vitro antileukemic effect of a new anthracycline analogue, MEN 11079.
Leukemia research 2003;27(12):1125-34.
2003: Rosa Fanci; C Paci; Franco Leoni; C Casini; G Longo
Ticarcillin-clavulanic acid plus amikacin versus ceftazidime plus amikacin in the empirical treatment of fever in acute leukemia: a prospective randomized trial.
Journal of chemotherapy (Florence, Italy) 2003;15(3):253-9.
2003: Franco Mandelli; Roberto Latagliata; Giuseppe Avvisati; Paola Fazi; Francesco Rodeghiero; Franco Leoni; marco gobbi; Francesco Nobile; Eugenio Gallo; R Fanin; Sergio Amadori; Marco Vignetti; Giuseppe Fioritoni; Felicetto Ferrara; Antonio Peta; Rosario Giustolisi; Giorgio Broccia; Maria Concetta Petti; Francesco Lo Coco
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.
Leukemia 2003;17(6):1085-90.
2002: Alessandro Pulsoni; Livio Pagano; Francesco Lo Coco; Giuseppe Avvisati; Luca Mele; Eros Di Bona; Rosangela Invernizzi; Franco Leoni; Filippo Marmont; Alfonso Mele; Lorella Melillo; Annamaria Nosari; Enrico Pogliani; Marco Vignetti; Giuseppe Visani; Vittorina Zagonel; Giuseppe Leone; Franco Mandelli
Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.
Blood 2002;100(6):1972-6.
2002: Franco Leoni; Giacomo Gianfaldoni; Mario Annunziata; Rosa Fanci; Stefania Ciolli; Carlo Nozzoli; Felicetto Ferrara
Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation.
Haematologica 2002;87(5):485-9.
2002: Felicetto Ferrara; Salvatore Palmieri; Barbara Pocali; Filiberto Pollio; Assunta Viola; Silvana Annunziata; Lucia Sebastio; Ettore Mariano Schiavone; Giuseppina Mele; Giacomo Gianfaldoni; Franco Leoni
De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG).
European journal of haematology 2002;68(4):203-9.
2002: Franco Leoni; Andrea Zaliani; Giorgio Bertolini; Giulia Porro; Paolo Pagani; Pietro Pozzi; Giancarlo Donà; Gianluca Fossati; Silvano Sozzani; Tania Azam; Philip Bufler; Giamila Fantuzzi; Igor Goncharov; Soo-Hyun Kim; Benjamin J Pomerantz; Leonid L Reznikov; Britta Siegmund; Charles A Dinarello; Paolo Mascagni
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):2995-3000.
2002: Davide Agnello; Eugenio Scanziani; Giancamillo Mauro Di; Franco Leoni; Daniela Modena; Paolo Mascagni; Martino Introna; Pietro Ghezzi; Pia Villa
Preventive administration of Mycobacterium tuberculosis 10-kDa heat shock protein (hsp10) suppresses adjuvant arthritis in Lewis rats.
International immunopharmacology 2002;2(4):463-74.
2001: Felicetto Ferrara; F Morabito; Roberto Latagliata; Bruno Martino; Mario Annunziata; Esther Oliva; Ettore Mariano Schiavone; Filiberto Pollio; Salvatore Palmieri; Giacomo Gianfaldoni; Franco Leoni
Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission.
Haematologica 2001;86(8):814-20.
2001: Giuseppe Visani; P Bernasconi; M Boni; G L Castoldi; Stefania Ciolli; Marino Clavio; m christina cox; A Cuneo; Giovanni Del Poeta; D Dini; Daniela Falzetti; Renato Fanin; marco gobbi; Alessandro Isidori; Franco Leoni; V Liso; Michele Malagola; giovanni martinelli; Cristina Mecucci; Pier Paolo Piccaluga; Maria Concetta Petti; Roberto Rondelli; Domenico Russo; Mario Sessarego; Giorgina Specchia; Nicoletta Testoni; G Torelli; Franco Mandelli; Sante Tura
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Leukemia 2001;15(6):903-9.
2001: G Visani; Donald Milligan; Franco Leoni; J Chang; S Kelsey; R Marcus; R Powles; Steve Schey; A Covelli; Alessandro Isidori; Litchman Manuel; P P Piccaluga; H Mayer; Michele Malagola; C Pfister
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia.
Leukemia 2001;15(5):764-71.
2001: Franco Leoni; Stefania Ciolli; Carlo Nozzoli; Valeria Santini; Rosa Fanci; Pierluigi Rossi Ferrini
Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
Haematologica 2001;86(1):104.
2000: Rosa Fanci; C Paci; RL Martinez; A Fabbri; Patrizia Pecile; Franco Leoni; G Longo
Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Journal of chemotherapy (Florence, Italy) 2000;12(3):232-9.
2000: Alberto Grossi; A Fabbri; Valeria Santini; Franco Leoni; Carlo Nozzoli; Giovanni Longo; Gabriella Pagliai; Stefania Ciolli; Pierluigi Rossi Ferrini
Amifostine in the treatment of low-risk myelodysplastic syndromes.
Haematologica 2000;85(4):367-71.
1999: Felicetto Ferrara; Franco Leoni; A Pinto; Salvatore Mirto; E Morra; Vittorina Zagonel; Giuseppina Mele; Stefania Ciolli; Silvana Magrin; Marco Montillo
Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes.
Cancer 1999;86(10):2006-13.
1999: Felicetto Ferrara; Lorella Melillo; Marco Montillo; Franco Leoni; A Pinto; Giuseppina Mele; Salvatore Mirto
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation.
Annals of hematology 1999;78(8):380-4.
1998: Silvia Linari; Alessandro M Vannucchi; Stefania Ciolli; Franco Leoni; Roberto Caporale; Alberto Grossi; Gabriella Pagliai; Valeria Santini; Francesco Paoletti; Pierluigi Rossi Ferrini
Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias.
British journal of haematology 1998;102(5):1335-7.
1998: Giulia Porro; G Bertolini; M A Bonardi; E Giovanetti; P Lento; Franco Leoni; Daniela Modena; G Pavich; F Marcucci
Diaminic carbonates, a new class of anti-inflammatory compounds: their biological characterization and mode of action.
The Journal of pharmacology and experimental therapeutics 1998;285(1):193-200.
1997: Giovanna Meloni; Marco Vignetti; Enrico Pogliani; Rosangela Invernizzi; Bernardino Allione; Salvatore Mirto; S Sica; Franco Leoni; C Selleri; Franco Mandelli
Interleukin-2 therapy in relapsed acute myelogenous leukemia.
The cancer journal from Scientific American 1997;3 Suppl 1():S43-7.
1997: Franco Leoni; Stefania Ciolli; Carlo Nozzoli; C Marrani; Roberto Caporale; Pierluigi Rossi Ferrini
Idarubicin in induction treatment of acute myeloid leukemia in the elderly.
Haematologica 1997;82(5 Suppl):13-8.
1997: Franco Mandelli; Daniela Diverio; Giuseppe Avvisati; A Luciano; Tiziano Barbui; C Bernasconi; Giorgio Broccia; Raffaella Cerri; Michele Falda; Giuseppe Fioritoni; Franco Leoni; Vincenzo Liso; Maria Concetta Petti; Francesco Rodeghiero; Giuseppe Saglio; Maria Luce Vegna; Giuseppe Visani; Ulrich Jehn; Rein Willemze; Petra Muus; Pier Giuseppe Pelicci; Andrea Biondi; Francesco Lo Coco
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.
Blood 1997;90(3):1014-21.
1997: G Bertolini; M Aquino; M Biffi; G d'Atri; F Di Pierro; F Ferrario; Paolo Mascagni; F Somenzi; Andrea Zaliani; Franco Leoni
A new rational hypothesis for the pharmacophore of the active metabolite of leflunomide, a potent immunosuppressive drug.
Journal of medicinal chemistry 1997;40(13):2011-6.
1997: F Di Pierro; G d'Atri; F Marcucci; Franco Leoni
Use of type I and type IV hypersensitivity responses to define the immunopharmacological profile of drugs.
Journal of pharmacological and toxicological methods 1997;37(2):91-6.
1996: Franco Leoni; R Fabbri; A Pascarella; C Marrani; Carlo Nozzoli; Stefania Ciolli; G Marchetti; Pierluigi Rossi Ferrini
Extramedullary haematopoiesis in thyroid multinodular goitre preceding clinical evidence of agnogenic myeloid metaplasia.
Histopathology 1996;28(6):559-61.
1996: Alberta Azzi; S Ciappi; R De Santis; Rosa Fanci; Franco Leoni; S Colli; Pierluigi Rossi Ferrini
Hemorrhagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia.
American journal of hematology 1996;52(2):121-2.
1995: A Pascarella; C Marrani; Franco Leoni; Stefania Ciolli; Carlo Nozzoli; Roberto Caporale; F Salti; Pierluigi Rossi Ferrini
Low-dose cytosine arabinoside in patients with acute myeloid leukemia not eligible for standard chemotherapy.
Leukemia & lymphoma 1995;18(5-6):465-9.
1995: Franco Leoni; Stefania Ciolli; G Giuliani; A Pascarella; Roberto Caporale; F Salti; L Cervi; Pierluigi Rossi Ferrini
Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results.
British journal of haematology 1995;90(1):169-74.
1994: M Leone; M Biffi; Franco Leoni; G Bussone
Leukocyte subsets and cortisol serum levels in patients with migraine without aura and chronic tension-type headache.
Cephalalgia : an international journal of headache 1994;14(2):139-42.
1994: F Chiaffarino; M Biffi; A Luciano; G Gromo; Franco Leoni
Involvement of multiple protein kinases in CD3-mediated activation of human T lymphocytes.
Cellular immunology 1994;153(1):39-51.
1993: Stefania Ciolli; Franco Leoni; Roberto Caporale; A Carbone; P Francia di Celle; R Foà; Pierluigi Rossi Ferrini
Mixed acute leukemia with genotypic lineage switch: a case report.
Leukemia 1993;7(7):1061-5.
1993: Stefania Ciolli; Franco Leoni; Roberto Caporale; A Pascarella; F Salti; Pierluigi Rossi Ferrini
CD34 expression fails to predict the outcome in adult acute myeloid leukemia.
Haematologica 1993;78(3):151-5.
1993: Rosa Fanci; Franco Leoni; Alberto Bosi; Stefano Guidi; Stefania Ciolli; Giovanni Longo; E Donnini; Pierluigi Rossi Ferrini
Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin.
Journal of chemotherapy (Florence, Italy) 1993;5(2):119-23.
1993: Franco Leoni; Stefania Ciolli; A Pascarella; Rosa Fanci; Roberto Caporale; Pierluigi Rossi Ferrini
Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patients.
Chemotherapy 1993;39(2):147-52.
1993: Pierluigi Rossi Ferrini; Valeria Santini; Stefania Ciolli; Alberto Grossi; Franco Leoni; D Rafanelli; Alessandro M Vannucchi
The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Hematological oncology 1993;11 Suppl 1():32-5.
1992: Franco Leoni; Stefania Ciolli; Roberto Caporale; F Salti; Pierluigi Rossi Ferrini
Continuous-infusion cyclophosphamide in combination with teniposide and dexamethasone in refractory myeloma.
Leukemia & lymphoma 1992;7(5-6):481-7.
1991: Stefania Ciolli; Franco Leoni; Roberto Caporale; F Salti; Pierluigi Rossi Ferrini
Continuous-infusion cyclophosphamide plus vincristine, cytosine-arabinoside and prednisone for refractory acute lymphoblastic leukemia in adults.
Haematologica 1991;76(4):293-7.
1991: Giuseppe Bandini; Elisa Zuffa; Gianantonio Rosti; R Battista; E D'Emilio; Franco Leoni; Stefania Ciolli; T Barbui; R Bassan; Giuseppe Todeschini
Long-term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years.
British journal of haematology 1991;77(4):486-90.
1991: Franco Leoni; Stefania Ciolli; F Salti; P Teodori; Pierluigi Rossi Ferrini
Teniposide, dexamethasone and continuous-infusion cyclophosphamide in advanced refractory myeloma.
British journal of haematology 1991;77(2):180-4.
1990: Franco Leoni; Stefania Ciolli; S Patriarchi; M Morfini; Pierluigi Rossi Ferrini
Etoposide in remission induction of adult acute myeloid leukemia.
Acta haematologica 1990;83(2):82-5.
1989: Pierluigi Rossi Ferrini; Stefania Ciolli; Franco Leoni
Low dose cytosine arabinoside in adult acute non-lymphoid leukemia.
Bone marrow transplantation 1989;4 Suppl 1():36-7.
1988: Franco Leoni; Stefania Ciolli; Giovanni Longo; A Messori; Pierluigi Rossi Ferrini
13-cis-Retinoic acid treatment in patients with myelodysplastic syndrome.
Acta haematologica 1988;80(1):8-12.
1987: Giuseppe Bandini; Michele Baccarani; G Cavazzini; R Battista; Franco Leoni; E Morra; B Comotti; G Scapoli; Giuseppe Todeschini; L Mangoni
Treatment of acute non lymphocytic leukemia. Results of a prospective trial of daunorubicin, arabinosylcytosine and 6-thioguanine (DAT) versus DAT plus vindesine and etoposide.
Haematologica 1987;72(5):431-7.
1987: Franco Leoni; Pierluigi Rossi Ferrini; G L Castoldi; M Pata; G F Del Prete; P Tomasi
Simultaneous occurrence of chronic granulocytic leukemia and chronic lymphoid leukemia.
Haematologica 1987;72(3):253-6.
1985: Giuseppe Bandini; B Comotti; G Scapoli; Franco Leoni; U Di Prisco; L Mangoni; R Battista; S Tura
Effect of 4-demethoxydaunorubicin (4-DMDR) in chronic myeloid leukemia in blastic transformation and relapsed acute leukemias.
Haematologica 1985;70(2):155-9.